Novel therapeutic agents in ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference144 articles.
1. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of ovarian cancer;Ann Oncol,2001
2. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma;Ahmed;J Clin Oncol,1996
3. Cancer statistics, 2001;Greenlee;CA Cancer J Clin,2001
4. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds;Gore;Gynecol Oncol,1990
5. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;Parmar;Lancet,2003
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions;Life;2024-03-06
2. Antigen-specific active immunotherapy for ovarian cancer;Cochrane Database of Systematic Reviews;2018-09-10
3. Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting unfavorable outcomes;Oncology Letters;2017-11-09
4. Treating cancer with infection: a review on bacterial cancer therapy;Letters in Applied Microbiology;2015-06-16
5. Antigen-specific active immunotherapy for ovarian cancer;Cochrane Database of Systematic Reviews;2014-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3